What are SGLT2 Inhibitor Drugs?
nvokana and Invokamet are classified as SGLT2 inhibitor drugs. These drugs are commonly prescribed for the treatment of Type 2 diabetes and work by helping the kidneys to lower blood glucose levels.
Amputation, Ketoacidosis and Kidney Problem Lawsuits
The FDA has issued warnings about potential serious side effects from taking SGLT2 inhibitors, including an increased risk of amputation, ketoacidosis and kidney problems. Lawsuits being filed against the manufacturers of Invokana and other SGTL2 inhibitor drugs allege that they failed to adequately warn users of these risks. If you or a loved one has suffered any of these conditions after using these products, you may be eligible for a cash settlement. Complete the form on this page to see if you may qualify for compensation.
There is a limited time to file your claim!